
Protein, Levodopa & Metabolic Management
May 21, 2026 at 19:00 (London)
Food As Medicine for Parkinson’s Series Part 5: Protein, Levodopa & Metabolic Management
As we move into the fifth part of our "Food is Medicine" series, we shift our focus to one of the most critical daily challenges for people with Parkinson’s Disease: the relationship between dietary protein and medication effectiveness. This session is designed to be the perfect next step for those who have mastered the basics and are ready for an advanced, highly specific look at metabolic management.
Protein is essential not only for anabolic health but for the production of dopamine itself. But for those taking Levodopa, it can be a double-edged sword. Because specific amino acids in protein use the same transport carrier as your L-dopa medication, the timing of taking specific protein food in relation to L-dopa, needs to be precise.
This webinar provides a specific and practical roadmap for timing protein intake relative to the time of taking L-dopa. The results will demonstrate how specialised individualised monitoring of drug response can manage the dreaded “off” periods and enable best efficacy of L-dopa. The presentation will also highlight the different metabolic processes that need to be supported in Parkinson’s Disease as well as Multidisciplinary Management.
About the Speaker: Lucille Leader (www.lucilleleader.com)
Lucille Leader is a renowned figure in the field of Nutritional Therapy specifically tailored for Parkinson’s Disease. Based in London, she has spent decades bridging the gap between clinical neurology and nutritional science. She is a Nutrition Director of the Parkinson’s Disease Integrated Nutrition Clinic and has authored and co-authored several definitive texts in peer reviewed Journals, including Movement Disorders and six Books on Parkinson’s Disease, including leading Neurologists and Parkinson’s Disease Health Care Specialists.
Her work has earned her the “Quality of Life in Parkinson’s Disease Award” from the United States of America, the “Outstanding Practice Award” and the “Highly Commended Outstanding Practice Award” in the UK.
She has been a Member of the Forum for Food and Health of the Royal Society of Medicine in London UK and Lecturer on Academic MSc Degree Courses in Parkinson’s Disease, Multiple Sclerosis and Medical Collaboration for Nutritional Therapists.
She has lectured at International Parkinson’s Disease Congresses.
Lucille is celebrated for her "bench-to-bedside" approach, taking complex metabolic processes and turning them into manageable, daily protocols. Her work focuses on the biochemical support of pathways that support dopamine production and other biochemical needs which contribute to functional health in Parkinson’s Disease.
Her mission, with that of her Clinic Medical Director Dr Geoffrey Leader, is to enable people with Parkinson’s and their Supporters / Carers to become empowered with as much knowledge as possible of Parkinson’s Drugs, Nutrients, Drug - Nutrient Interactions, Support of Essential Biochemical Needs, Intestinal Function and Management of Cellular Energy, amongst other aspects.
Active empowerment produces a feeling of well-being for both people with Parkinson’s and their Supporters,
She is also aware that Parkinson’s has multi-factorial implications and therefore recommends a multidisciplinary team approach, working always in collaboration with patients’ GPs and specialists for referrals to the appropriate healthcare professionals.
Lucille is celebrated for her "bench-to-bedside" approach, taking complex metabolic processes and turning them into manageable, daily protocols. Clinical Nutrition is Applied Biochemistry and her work therefore focuses on metabolic support that serves optimum cellular function within the confines of Parkinson’s Disease.
Submit a question
Share your question for this upcoming webinar. The most liked questions will be asked of the speaker during the webinar.
Please log in to submit a question.
Submitted questions
Log in to like questions.
No submitted questions yet.